The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation.

[1]  E. Şahan,et al.  The MOGE(S) classification , 2016, Herz.

[2]  L. Al-Shaar,et al.  Primary carnitine deficiency: novel mutations and insights into the cardiac phenotype , 2014, Clinical genetics.

[3]  J. Niezgoda,et al.  Anesthetic considerations in patients with mitochondrial defects , 2013, Paediatric anaesthesia.

[4]  P. Chinnery,et al.  Mitochondrial genetics , 2013, British medical bulletin.

[5]  Y. Pinto,et al.  Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy: overview of 10 years' experience , 2013, European journal of heart failure.

[6]  Perry M Elliott,et al.  A systematic review and meta-analysis of genotype–phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations , 2013, Heart.

[7]  Y. Pinto,et al.  Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.

[8]  J. Towbin,et al.  Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians. , 2013, Journal of the American College of Cardiology.

[9]  F. Rivier,et al.  Natural history of Barth syndrome: a national cohort study of 22 patients , 2013, Orphanet Journal of Rare Diseases.

[10]  E. Rampersaud,et al.  Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy. , 2013, Journal of cardiac failure.

[11]  B. Lindsay,et al.  ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, Ameri , 2013, Heart rhythm.

[12]  E. Zaklyazminskaya,et al.  Cardiac channelopathies: genetic and molecular mechanisms. , 2013, Gene.

[13]  Luca Segreti,et al.  Superior vena cava defibrillator coils make transvenous lead extraction more challenging and riskier. , 2013, Journal of the American College of Cardiology.

[14]  M. Ashworth,et al.  Barth syndrome , 2013, Orphanet Journal of Rare Diseases.

[15]  R. Desnick,et al.  Morbidity and mortality in type B Niemann–Pick disease , 2013, Genetics in Medicine.

[16]  A. Ferlini,et al.  The medical genetics of dystrophinopathies: Molecular genetic diagnosis and its impact on clinical practice , 2013, Neuromuscular Disorders.

[17]  Mark A Hlatky,et al.  2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2013, Circulation.

[18]  P. V. D. van der Starre,et al.  Late profound muscle weakness following heart transplantation due to danon disease , 2013, Muscle & nerve.

[19]  C. Berul,et al.  An Update on Channelopathies: From Mechanisms to Management , 2013, Circulation.

[20]  S. Strelkov,et al.  Desminopathies: pathology and mechanisms , 2012, Acta Neuropathologica.

[21]  A. El-Hattab,et al.  Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management , 2012, Orphanet Journal of Rare Diseases.

[22]  Robert W. Taylor,et al.  Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management , 2012, European heart journal.

[23]  L. Anderson,et al.  Cardiac transthyretin amyloidosis , 2012, Heart.

[24]  G. R. Wagner,et al.  Cardiomyopathy in Friedreich Ataxia , 2012, Journal of Child Neurology.

[25]  M. Ashworth,et al.  Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy. , 2012, European heart journal.

[26]  J. Seward,et al.  Left ventricular noncompaction: a 25-year odyssey. , 2012, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[27]  L. Mestroni,et al.  Truncations of titin causing dilated cardiomyopathy. , 2012, The New England journal of medicine.

[28]  P. Elliott,et al.  Long-Term Outcomes in Hypertrophic Cardiomyopathy Caused by Mutations in the Cardiac Troponin T Gene , 2012, Circulation. Cardiovascular genetics.

[29]  A. Zwinderman,et al.  Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. , 2012, Journal of the American College of Cardiology.

[30]  R. Falk,et al.  Cardiac amyloidosis. , 2012, Circulation.

[31]  B. Maron,et al.  Double or compound sarcomere mutations in hypertrophic cardiomyopathy: a potential link to sudden death in the absence of conventional risk factors. , 2012, Heart rhythm.

[32]  P. Jouk,et al.  Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy. , 2011, European journal of medical genetics.

[33]  A. Tajik,et al.  Isolated noncompaction of the left ventricular myocardium in adults: a systematic overview. , 2011, Journal of cardiac failure.

[34]  L. Tavazzi,et al.  Diagnostic work-up and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin defects. , 2011, Journal of the American College of Cardiology.

[35]  P. Elliott,et al.  Desmosomal protein gene mutations in patients with idiopathic dilated cardiomyopathy undergoing cardiac transplantation: a clinicopathological study , 2011, Heart.

[36]  Michael J Ackerman,et al.  HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[37]  M. Baumann,et al.  Analysis of myotilin turnover provides mechanistic insight into the role of myotilinopathy-causing mutations. , 2011, The Biochemical journal.

[38]  R. Hershberger,et al.  Update 2011: clinical and genetic issues in familial dilated cardiomyopathy. , 2011, Journal of the American College of Cardiology.

[39]  S. Ozen,et al.  Renal amyloidosis in children , 2011, Pediatric Nephrology.

[40]  Y. Capetanaki,et al.  Desmin‐related myopathy , 2011, Clinical genetics.

[41]  J. Stockman.  Clinical Outcome and Phenotypic Expression in LAMP2 Cardiomyopathy , 2011 .

[42]  L. Tavazzi,et al.  When should cardiologists suspect Anderson-Fabry disease? , 2010, The American journal of cardiology.

[43]  A. Keren,et al.  Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2010, European heart journal.

[44]  I. Nishino,et al.  State of the art in muscle lipid diseases , 2010, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[45]  E. Arbustini,et al.  Restrictive cardiomyopathy , 2009, Current opinion in cardiology.

[46]  L. Mestroni,et al.  Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline. , 2009, Journal of cardiac failure.

[47]  B. Maisch,et al.  Kardiomyopathien und Myokardbiopsie im Spiegel der neuen Klassifikationen , 2009, Herz Kardiovaskuläre Erkrankungen.

[48]  V. Ruppert,et al.  [Classification of cardiomyopathies and indication for endomyocardial biopsy revisited]. , 2009, Herz.

[49]  Claudia Stöllberger,et al.  Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2009, Heart rhythm.

[50]  K. Claeys,et al.  Differential involvement of sarcomeric proteins in myofibrillar myopathies: a morphological and immunohistochemical study , 2009, Acta Neuropathologica.

[51]  Dudley J Pennell,et al.  Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. , 2008, Journal of the American College of Cardiology.

[52]  W. Giles,et al.  Cardiac troponin T mutations promote life-threatening arrhythmias. , 2008, The Journal of clinical investigation.

[53]  Christopher Semsarian,et al.  Proceedings of the Australian Physiological Society Symposium: Influencing Factors in the Fate of Cardiac Myocytes in Heart Disease IMPACT OF MULTIPLE GENE MUTATIONS IN DETERMINING THE SEVERITY OF CARDIOMYOPATHY AND HEART FAILURE , 2008 .

[54]  L. Tavazzi,et al.  Long-term outcome and risk stratification in dilated cardiolaminopathies. , 2008, Journal of the American College of Cardiology.

[55]  F. Berger,et al.  Mutations in Sarcomere Protein Genes in Left Ventricular Noncompaction , 2008, Circulation.

[56]  A. Amato,et al.  Pompe Disease: A Review of the Current Diagnosis and Treatment Recommendations in the Era of Enzyme Replacement Therapy , 2008, Journal of clinical neuromuscular disease.

[57]  J. Ornato,et al.  ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2008, Heart rhythm.

[58]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Journal of the American College of Cardiology.

[59]  A. Keren,et al.  [Classification of the cardiomyopathies]. , 2008, Kardiologia polska.

[60]  Eloisa Arbustini,et al.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.

[61]  E. Arbustini,et al.  Pure restrictive cardiomyopathy associated with cardiac troponin I gene mutation: mismatch between the lack of hypertrophy and the presence of disarray , 2007, Heart.

[62]  S. Bharati,et al.  Cardiomyopathy in multiple Acyl-CoA dehydrogenase deficiency: a clinico-pathological correlation and review of literature. , 2008, Pediatric cardiology.

[63]  E. Arbustini,et al.  Noncompaction of the left ventricle: primary cardiomyopathy with an elusive genetic etiology , 2007, Current opinion in pediatrics.

[64]  G. Nemer,et al.  Exclusive cardiac dysfunction in familial primary carnitine deficiency cases: a genotype–phenotype correlation , 2007, Clinical genetics.

[65]  C. Polman,et al.  High frequency of creatine deficiency syndromes in patients with unexplained mental retardation , 2006, Neurology.

[66]  L. Tavazzi,et al.  Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects , 2006, European journal of heart failure.

[67]  Barry J Maron,et al.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.

[68]  D. Corrado,et al.  Is it time to include ion channel diseases among cardiomyopathies? , 2005, Journal of electrocardiology.

[69]  R. Hershberger,et al.  Clinical and genetic issues in familial dilated cardiomyopathy. , 2005, Journal of the American College of Cardiology.

[70]  J. Seidman,et al.  Glycogen storage diseases presenting as hypertrophic cardiomyopathy. , 2005, The New England journal of medicine.

[71]  Yiming Wu,et al.  Altered Titin Expression, Myocardial Stiffness, and Left Ventricular Function in Patients With Dilated Cardiomyopathy , 2004, Circulation.

[72]  G. Valle,et al.  Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. , 2003, Journal of the American College of Cardiology.

[73]  Giampaolo Merlini,et al.  Molecular mechanisms of amyloidosis. , 2003, The New England journal of medicine.

[74]  P. Bross,et al.  Clear relationship between ETF/ETFDH genotype and phenotype in patients with multiple acyl‐CoA dehydrogenation deficiency , 2003, Human mutation.

[75]  D. Driscoll,et al.  Myosin Light Chain Mutation Causes Autosomal Recessive Cardiomyopathy With Mid-Cavitary Hypertrophy and Restrictive Physiology , 2002, Circulation.

[76]  P. Venugopalan,et al.  Cardiac involvement in infantile Sandhoff disease , 2002, Journal of paediatrics and child health.

[77]  E. Arbustini,et al.  Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis , 2002, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[78]  J. Weissenbach,et al.  Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome. , 2001, American journal of human genetics.

[79]  L. Tavazzi,et al.  Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy. , 2000, Journal of the American College of Cardiology.

[80]  P. Elliott,et al.  The molecular genetics of hypertrophic cardiomyopathy: prognostic implications. , 2000, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[81]  E. Arbustini,et al.  The new apolipoprotein A-I variant leu(174) --> Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide. , 1999, The American journal of pathology.

[82]  E. Arbustini,et al.  Restrictive cardiomyopathy, atrioventricular block and mild to subclinical myopathy in patients with desmin-immunoreactive material deposits. , 1998, Journal of the American College of Cardiology.

[83]  N. Gregersen,et al.  Fatty acid oxidation disorders as primary cause of sudden and unexpected death in infants and young children: an investigation performed on cultured fibroblasts from 79 children who died aged between 0-4 years. , 1997, Molecular pathology : MP.

[84]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[85]  E. Arbustini,et al.  Dilated cardiomyopathy requiring cardiac transplantation as initial manifestation of Xp21 Becker type muscular dystrophy , 1994, Neuromuscular Disorders.

[86]  H. Rosenberg,et al.  Cardiac involvement in diseases characterized by β-galactosidase deficiency , 1985 .

[87]  H. Rosenberg,et al.  Cardiac involvement in diseases characterized by beta-galactosidase deficiency. , 1985, The Journal of pediatrics.

[88]  H. Goebel,et al.  Infantile cardiomyopathy and neuromyopathy with beta-galactosidase deficiency. , 1982, European journal of pediatrics.

[89]  C. Kawai,et al.  Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. , 1980, British heart journal.

[90]  H. Snellen.  Birth and growth of the European Society of Cardiology. , 1980, European heart journal.

[91]  O. Eliseev.  [Cardiac amyloidosis]. , 1980, Terapevticheskii arkhiv.

[92]  P. Benson,et al.  GM1-generalized gangliosidosis variant with cardiomegaly , 1976, Postgraduate medical journal.

[93]  J. Moller,et al.  Generalized accumulation of neutral glycosphingolipids with GM2 ganglioside accumulation in the brain. Sandhoff's disease (variant of Tay-Sachs disease). , 1972, The American journal of medicine.

[94]  J. Hagstrom,et al.  Cardiac lesions in a patient with familial neurovisceral lipidosis (generalized gangliosidosis). , 1971, American journal of clinical pathology.

[95]  C. Oakley,et al.  The cardiomyopathies. , 1972, British heart journal.

[96]  W. Brigden.  Uncommon myocardial diseases: the non-coronary cardiomyopathies. , 1957, Lancet.

[97]  E. Gall,et al.  Myocarditis and Myocardosis: A Clinicopathologic Appraisal , 1956, Circulation.